Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer CEO: Our CAR-T development method could give us a leg up over Kite, Juno, Novartis
Pfizer CEO: Our CAR-T development method could give us a leg up over Kite, Juno, Novartis
Pfizer CEO: Our CAR-T development method could give us a leg up over Kite, Juno, Novartis
Submitted by
admin
on January 14, 2016 - 8:54pm
Source:
BioPharma Dive
News Tags:
Pfizer
Pharma CEOs
Ian Read
R&D
CAR-T
Novartis
Juno Therapeutics
Kite Pharma
Headline:
Pfizer CEO: Our CAR-T development method could give us a leg up over Kite, Juno, Novartis
Do Not Allow Advertisers to Use My Personal information
